Company
Headquarters: Taipei, Taiwan
TW$30.65 Billion
TWD as of Jan. 1, 2025
US$933.9 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $689.42 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $487.54 B |
| Johnson & Johnson | $353.05 B |
| AbbVie | $301.60 B |
Center Laboratories, Inc. operates as a pharmaceutical company in Taiwan. It engages in the research and development of small molecule drugs; manufacture and sale of pharmaceuticals; development of proteins and antibodies; and pharmaceutical CDMO, medical device, nutritional health and agribiotechnology, stem cell and immune cell therapy, and industry investment fund and venture capital businesses. The company was founded in 1959 and is headquartered in Taipei, Taiwan.
Top 1-year algo backtest: +327.04%
$10,000 in March 2024 would now be $42,704 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
| Last Financial Reports Date | Sept. 30, 2024 |
| Revenue TTM | TW$1.52 B |
| EBITDA | TW$313.2 M |
| Gross Profit TTM | TW$618.1 M |
| Profit Margin | -109.45% |
| Operating Margin | 13.58% |
| Quarterly Revenue Growth | 32.40% |
Center Laboratories, Inc. has the following listings and related stock indices.
Stock: TWSE: 4123 wb_incandescent